Toronto, Ontario–(Newsfile Corp. – March 25, 2025) – Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) (“Glow” or the “Company“) is accelerating its expansion with the acquisition of a new automated bottling line to support the rapid growth of its MOD™ product portfolio in Canada. This strategic investment triples the Company’s production capacity, reinforcing its high-margin, capital-efficient growth strategy as it scales to meet increasing market demand.
Scaling Production for Growth
Glow’s new automated bottling system streamlines the entire MOD™ bottling process, significantly increasing production output while reducing labor costs, further enhancing the Company’s high-margin, scalable business model. With demand growing rapidly, this system allows Glow to accelerate supply and support its continued expansion with enhanced reliability and cost-effectiveness.
“Glow is in a strong growth phase, and this investment in automation not only scales production to meet the rising demand, but also improves efficiency, further strengthening profitability as we grow,” said Rob Carducci, CEO of Glow Lifetech. “With our retail footprint surpassing 850 stores, strong consumer demand continues to drive momentum. We are seeing growing interest from new provinces, positioning us to accelerate growth and capture new opportunities in the near term.”
Retail Footprint Expands to 850+ Stores as Growth Accelerates
Glow continues to expand its retail presence at an aggressive pace, with its products now available in over 850+ cannabis retail stores across Ontario—a 30% increase from Q4 2024. This rapid growth underscores the increasing demand for Glow’s fast-acting, water-soluble cannabis formats and the effectiveness of its go-to-market execution. With 1,700+ stores in Ontario alone, the Company sees significant room for further growth as it deepens relationships with retailers and expands into new provinces.
Market Leadership: MOD™ THC 1000 Achieves #2 Oils SKU in Ontario
Glow’s continued market leadership has been further validated with the MOD™ THC 1000 innovation achieving the #2 ranked SKU in Ontario’s oils category[1], reinforcing MOD™’s position as the #3 cannabis oils brand in the province. This rapid rise highlights the strength of Glow’s differentiated product strategy and consumer appeal.
“Achieving the #2 spot in Ontario’s oils category with our MOD™ THC 1000 is a clear indication of our product’s strong consumer demand and the effectiveness of our strategy,” said Rob Carducci, CEO of Glow Lifetech. “This performance reinforces our position as a leading cannabis brand in Ontario, and we see significant potential for further growth as we expand into new markets and continue to scale production.”
Positioned for Continued Growth
Glow remains in the early innings of its commercial journey, with significant headroom for further expansion. With a scaled-up production infrastructure, expanding retail footprint, and increasing market share, the Company is solidifying its foundation while advancing strategic expansion plans into new provinces throughout 2025.
Recent News
The Company recently announced a commercial update highlighting its continued market momentum and solid start to 2025, new product innovation, and strategic expansion plans. Full story here: https://bit.ly/4ixAdLF.
SUBSCRIBE: For more information on Glow or to subscribe to the Company’s mail list visit: https://www.glowlifetech.com/news
About Glow Lifetech Corp
Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.
Website: www.glowlifetech.com
Contact:
Rob Carducci, CEO
Glow Lifetech Corp.
TF. 855-442-GLOW (4569)
ir@glowlifetech.com
Forward-Looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements with respect to the proposed Debt Settlement, including the amount and completion thereof and statements regarding the Offering, including the amount of proceeds expected to be raised, the timing for closing, the receipt of required regulatory approvals and the intended use of proceeds. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the Offering and Debt Settlement described in this news release will be completed on the terms described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedarplus.ca.
[1] Based on $ Sales – 2025 OCS Wholesale Data, Year to Date
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/245862
Pioneering cancer immunology company Asgard strengthens leadership team as it progresses its lead asset AT-108…
SHANGHAI, March 26, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader…
Ottawa, Ontario--(Newsfile Corp. - March 26, 2025) - The Canadian Nurses Association (CNA), representing Canada's…
Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF)…
In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is…
STUART, Fla., March 25, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform…